Published in Biochem J on January 01, 1974
SGLT2 Inhibitors May Predispose to Ketoacidosis. J Clin Endocrinol Metab (2015) 3.11
A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. Biochem J (1985) 2.77
A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci U S A (2004) 2.06
Effects of fasting on tissue glucose utilization in conscious resting rats. Major glucose-sparing effect in working muscles. Biochem J (1987) 1.93
Glucose metabolism in perfused skeletal muscle. Effects of starvation, diabetes, fatty acids, acetoacetate, insulin and exercise on glucose uptake and disposition. Biochem J (1976) 1.90
Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition (2010) 1.89
Brain lactate metabolism: the discoveries and the controversies. J Cereb Blood Flow Metab (2011) 1.71
Cerebral metabolic adaptation and ketone metabolism after brain injury. J Cereb Blood Flow Metab (2007) 1.70
Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat. Biochem J (1977) 1.69
Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes (2006) 1.65
Ketoacids? Good medicine? Trans Am Clin Climatol Assoc (2003) 1.40
The ketogenic diet: metabolic influences on brain excitability and epilepsy. Trends Neurosci (2012) 1.31
Factors affecting the utilization of ketone bodies and other substrates by rat jejunum: effects of fasting and of diabetes. J Physiol (1978) 1.29
Effect of citrate on the activities of 6-phosphofructokinase from nervous and muscle tissues from different animals and its relationships to the regulation of glycolysis. Biochem J (1977) 1.24
Effects of starvation and exercise on concentrations of citrate, hexose phosphates and glycogen in skeletal muscle and heart. Evidence for selective operation of the glucose-fatty acid cycle. Biochem J (1985) 1.13
Metabolic fuel and amino acid transport into the brain in experimental diabetes mellitus. Proc Natl Acad Sci U S A (1982) 1.05
The effects of age and ketogenic diet on local cerebral metabolic rates of glucose after controlled cortical impact injury in rats. J Neurotrauma (2009) 1.04
Hyperglycaemia and diabetes impair gap junctional communication among astrocytes. ASN Neuro (2010) 1.01
Increased GABAergic output in the ventromedial hypothalamus contributes to impaired hypoglycemic counterregulation in diabetic rats. Diabetes (2011) 1.00
The role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease. Int J Mol Sci (2012) 0.96
Ketosis proportionately spares glucose utilization in brain. J Cereb Blood Flow Metab (2013) 0.90
Ketones suppress brain glucose consumption. Adv Exp Med Biol (2009) 0.90
The contribution of ketone bodies to basal and activity-dependent neuronal oxidation in vivo. J Cereb Blood Flow Metab (2014) 0.87
The oxidation of glucose, ketone bodies and acetate by the brain of normal and ketonaemic sheep. J Physiol (1976) 0.86
Brain energy metabolism in streptozotocin-diabetes. Biochem J (1988) 0.84
Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester. J Lipid Res (2014) 0.83
Successful adaptation to ketosis by mice with tissue-specific deficiency of ketone body oxidation. Am J Physiol Endocrinol Metab (2012) 0.81
Fructose-2,6-bisphosphate is lower in copper deficient rat cerebellum despite higher content of phosphorylated AMP-activated protein kinase. Exp Biol Med (Maywood) (2008) 0.80
Sodium-glucose co-transporter-2 inhibitors and euglycemic ketoacidosis: Wisdom of hindsight. Indian J Endocrinol Metab (2015) 0.79
Cerebral ketone metabolism during development and injury. Epilepsy Res (2011) 0.79
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase in rat brain. Biochem J (1991) 0.77
Metabolic Response of Pediatric Traumatic Brain Injury. J Child Neurol (2014) 0.75
Acid-base safety during the course of a very low-calorie-ketogenic diet. Endocrine (2017) 0.75
Use of glucose oxidase, peroxidase, and O-dianisidine in determination of blood and urinary glucose. Lancet (1957) 19.82
Enzymic determination of D(-)-beta-hydroxybutyric acid and acetoacetic acid in blood. Biochem J (1962) 12.21
Brain metabolism during fasting. J Clin Invest (1967) 6.48
Hormone-fuel interrelationships during fasting. J Clin Invest (1966) 6.44
Metabolism of acetoacetate in animal tissues. 1. Biochem J (1945) 5.88
Activities of enzymes involved in acetoacetate utilization in adult mammalian tissues. Biochem J (1971) 3.48
Ketone-body utilization by adult and suckling rat brain in vivo. Biochem J (1971) 3.32
THE RELATIONSHIPS BETWEEN SUBSTRATES AND ENZYMES OF GLYCOLYSIS IN BRAIN. J Biol Chem (1964) 2.94
Effect of pH on the kinetics of frog muscle phosphofructokinase. J Biol Chem (1966) 2.68
Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism. Biochem J (1971) 2.66
Carbohydrate synthesis from lactate in pigeon-liver homogenate. Biochem J (1964) 2.50
Interactions of metabolism and the physiological role of insulin. Recent Prog Horm Res (1966) 2.00
Acetoacetate metabolism in infant and adult rat brain in vitro. Biochem J (1970) 1.93
The effects of starvation and alloxan-diabetes on the contents of citrate and other metabolic intermediates in rat liver. Biochem J (1968) 1.87
Control of glycolysis in cerebral cortex slices. Biochem J (1967) 1.74
Interconversion and kinetic properties of pyruvate dehydrogenase from brain. Hoppe Seylers Z Physiol Chem (1971) 1.67
Freeze-blowing: a new technique for the study of brain in vivo. J Neurochem (1973) 1.60
Metabolic interactions of glucose, lactate, and beta-hydroxybutyrate in rat brain slices. Am J Physiol (1969) 1.56
The effect of hypercapnia upon intracellular pH in the brain, evaluated by the bicarbonate-carbonic acid method and from the creatine phosphokinase equilibrium. J Neurochem (1972) 1.17
Phosphofructokinase. Curr Top Cell Regul (1972) 1.08
Glucose and lactic acid content of the rat brain. J Neurochem (1968) 1.05
CoA transferase in the brain and other mammalian tissues. Arch Biochem Biophys (1972) 1.04
The effect of ammonia on the energy metabolism of the rat brain. Life Sci II (1970) 1.02
Regulation of ketone body metabolism in skeletal muscle. Am J Physiol (1973) 0.98
The control of glycogen metabolism in the liver. FEBS Lett (1970) 0.98
The properties of glycogen synthetase and regulation of glycogen biosynthesis in rat brain. J Biol Chem (1969) 0.97
Factors influencing utilisation of ketone-bodies by brain in normal rats and rats with ketoacidosis. Lancet (1971) 0.96
Oxidation of glucose, acetoacetate, and palmitate in brain mince of normal and ketotic rats. Diabetes (1968) 0.91
[Utilization of non-esterified fatty acids and ketone nbodies in human brain]. Klin Wochenschr (1971) 0.87
The effects of altered endocrine states and of ether anaesthesia on mouse brain. J Neurochem (1971) 0.84
Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res (2000) 7.29
Cortical language localization in left, dominant hemisphere. An electrical stimulation mapping investigation in 117 patients. J Neurosurg (1989) 4.18
T lymphocyte-directed gene therapy for ADA- SCID: initial trial results after 4 years. Science (1995) 3.87
Attainment and adjustment in two geographical areas. I--The prevalence of psychiatric disorder. Br J Psychiatry (1975) 3.79
Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation (1990) 3.52
Hypoglycemic symptoms and frequency of severe hypoglycemia in patients treated with human and animal insulin preparations. Diabetes Care (1991) 3.51
Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. J Am Coll Cardiol (1985) 3.50
Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med (1995) 3.47
Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med (1994) 3.24
Human neutrophils increase expression of C3bi as well as C3b receptors upon activation. J Clin Invest (1984) 2.88
c-Jun and p53 activity is modulated by SUMO-1 modification. J Biol Chem (2000) 2.71
The "metabolically-obese," normal-weight individual. Am J Clin Nutr (1981) 2.71
Evaluation of the isolated perfused rat hindquarter for the study of muscle metabolism. Biochem J (1971) 2.66
Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J (1999) 2.64
Electron microscopic and biochemical study of lipoprotein synthesis in the isolated perfused rat liver. J Lipid Res (1967) 2.58
Contraction-induced changes in acetyl-CoA carboxylase and 5'-AMP-activated kinase in skeletal muscle. J Biol Chem (1997) 2.54
Absorption kinetics and biologic effects of subcutaneously injected insulin preparations. Diabetes Care (1987) 2.50
Muscle glucose metabolism following exercise in the rat: increased sensitivity to insulin. J Clin Invest (1982) 2.41
Association of asthma control with health care utilization and quality of life. Am J Respir Crit Care Med (1999) 2.36
Bicentric evaluation of a teaching and treatment programme for type 1 (insulin-dependent) diabetic patients: improvement of metabolic control and other measures of diabetes care for up to 22 months. Diabetologia (1983) 2.18
Role of different proteolytic systems in the degradation of muscle proteins during denervation atrophy. J Biol Chem (1990) 2.14
The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J Biol Chem (1994) 2.09
Sleep and depression--results from psychobiological studies: an overview. Biol Psychol (2001) 2.02
Effect of age on excess mortality in obesity. JAMA (1999) 2.01
Intensified insulin therapy and the risk of severe hypoglycaemia. Diabetologia (1997) 1.95
Oxidative damage to DNA: formation, measurement, and biological significance. Rev Physiol Biochem Pharmacol (1997) 1.91
The formation of glutamine and alanine in skeletal muscle. J Biol Chem (1974) 1.90
Glucose metabolism in perfused skeletal muscle. Effects of starvation, diabetes, fatty acids, acetoacetate, insulin and exercise on glucose uptake and disposition. Biochem J (1976) 1.90
Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. J Biol Chem (1993) 1.88
Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest-Düsseldorf Study. Diabetologia (1987) 1.87
Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Invest (1985) 1.85
Do angiotensin converting enzyme inhibitors represent a progress in hypertension care in diabetes mellitus? Diabetologia (1990) 1.84
Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. Am J Respir Cell Mol Biol (1995) 1.82
Glucose metabolism in perfused skeletal muscle. Interaction of insulin and exercise on glucose uptake. Biochem J (1975) 1.71
Effect of acetoacetate on glucose metabolism in the soleus and extensor digitorum longus muscles of the rat. Biochem J (1977) 1.69
Current understanding of the inflammatory process in cystic fibrosis: onset and etiology. Pediatr Pulmonol (1997) 1.68
Effective and safe translation of intensified insulin therapy to general internal medicine departments. Diabetologia (1993) 1.67
Pharmacokinetics and bioavailability of injected glucagon: differences between intramuscular, subcutaneous, and intravenous administration. Diabetes Care (1985) 1.67
Issues in the measurement of satisfaction with treatment. Am J Manag Care (1997) 1.67
Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin Invest (1990) 1.66
Evidence that lysosomes are not involved in the degradation of myofibrillar proteins in rat skeletal muscle. Biochem J (1986) 1.66
Glucose regulation of hepatic gluconeogenesis. Am J Physiol (1968) 1.64
Cross-sectional and longitudinal studies of naturally occurring antibodies to Pseudomonas aeruginosa in cystic fibrosis indicate absence of antibody-mediated protection and decline in opsonic quality after infection. J Infect Dis (1995) 1.63
Polyunsaturated fatty acids inhibit T cell signal transduction by modification of detergent-insoluble membrane domains. J Cell Biol (1998) 1.63
Assessment of excess mortality in obesity. Am J Epidemiol (1998) 1.62
Muscle amino acid metabolism and gluconeogenesis. Annu Rev Med (1975) 1.61
Role of free fatty acids in glucose homeostasis. Arch Intern Med (1969) 1.61
Prevalence and treatment of insomnia in general practice. A longitudinal study. Eur Arch Psychiatry Clin Neurosci (1993) 1.61
Glucose metabolism in rat skeletal muscle at rest. Effect of starvation, diabetes, ketone bodies and free fatty acids. Diabetes (1974) 1.61
Health beliefs and compliance with inhaled corticosteroids by asthmatic patients in primary care practices. Respir Med (1999) 1.59
Lack of binding of human C3, in its native state, to C3b receptors. J Immunol (1981) 1.57
Evaluation of a structured treatment and teaching programme on non-insulin-dependent diabetes. Lancet (1988) 1.56
Acetoacetate as a fuel for perfused rat skeletal muscle. Biochem J (1971) 1.54
Use of intravenously administered immune globulin to prevent nosocomial sepsis in low birth weight infants: report of a pilot study. J Pediatr (1989) 1.53
The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol (1997) 1.52
Localization of complement component 3 on Streptococcus pneumoniae: anti-capsular antibody causes complement deposition on the pneumococcal capsule. Infect Immun (1983) 1.51
Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand (1994) 1.51
Uncontrolled-rate freezing and storage at -80 degrees C, with only 3.5-percent DMSO in cryoprotective solution for 109 autologous peripheral blood progenitor cell transplantations. Transfusion (2001) 1.51
PCBs are a health risk for humans and wildlife. Science (2000) 1.51
Noninvasive estimation of pulmonary artery diastolic pressure in patients with tricuspid regurgitation by Doppler echocardiography. Chest (1999) 1.51
Action profiles of fast onset insulin analogues. Diabetologia (1990) 1.50
Obstructive sleep apnea is a risk factor for difficult endotracheal intubation. Minerva Anestesiol (2011) 1.49
Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood (1997) 1.48
Unsuspected cardiac abnormalities in the acquired immune deficiency syndrome. An echocardiographic study. Chest (1989) 1.48
Echocardiographic detection of transient right heart thrombus: now you see it, now you don't. Am Heart J (1991) 1.48
Functional differences between the 40 kDa and 50 to 70 kDa IgG Fc receptors on human neutrophils revealed by elastase treatment and antireceptor antibodies. J Immunol (1988) 1.48
Test-retest reliability and validity of the Structured Interview for Sleep Disorders According to DSM-III-R. Am J Psychiatry (1993) 1.46
Pyrimethamine concentrations in serum and cerebrospinal fluid during treatment of acute Toxoplasma encephalitis in patients with AIDS. J Infect Dis (1988) 1.45
Starvation in the rat. II. Effect of age and obesity on protein sparing and fuel metabolism. Am J Physiol (1980) 1.43
An insight into the epidemiology of dolphin morbillivirus worldwide. Vet Microbiol (2001) 1.43
Phosphatidylinositol-3-kinase in isolated rat adipocytes. Activation by insulin and subcellular distribution. J Biol Chem (1992) 1.43
Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load. J Clin Invest (1988) 1.42
Possible risk of sulfonylureas in the treatment of non-insulin-dependent diabetes mellitus and coronary artery disease. Diabetologia (1997) 1.42
Captopril, blood pressure, and diabetic nephropathy. JAMA (1994) 1.42
[Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities]. Nervenarzt (1996) 1.42
Prandial glycaemia after a carbohydrate-rich meal in type I diabetic patients: using the rapid acting insulin analogue [Lys(B28), Pro(B29)] human insulin. Diabet Med (1996) 1.41
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci (1997) 1.41
Muscle glycogenolysis during exercise: dual control by epinephrine and contractions. Am J Physiol (1982) 1.40
Leptinomimetic effects of the AMP kinase activator AICAR in leptin-resistant rats: prevention of diabetes and ectopic lipid deposition. Diabetologia (2004) 1.40
Hemodialysis of children: a review. Tex Med (1976) 1.40
Insulin binding and sensitivity in rat skeletal muscle: effect of starvation. Am J Physiol (1981) 1.39
[Differential indications for psychotherapy exemplified by depression]. Nervenarzt (2011) 1.39
[Significance of historical and current hallucinogenic research in psychiatry]. Nervenarzt (1993) 1.39
Diabetes care in cats and dogs. Diabet Med (2002) 1.39
[The metabolic effects of beta-receptor blockers. What is of practical importance in antihypertensive therapy?]. Dtsch Med Wochenschr (1992) 1.39
Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med (1992) 1.38
HLA-DR2 and sleep onset REM periods in endogenous depression. Br J Psychiatry (1988) 1.38
Altered respiratory epithelial cell cytokine production in cystic fibrosis. J Allergy Clin Immunol (1999) 1.38
Reliability of causes of death in persons with Type I diabetes. Diabetologia (2002) 1.38